Pilot study into the IgG1 and IgG2 subclass response to polyvalent Pseudomonas vaccine in burned adults.
The IgG1 and IgG2 subclass response to thermal injury has been measured in a group of eight burned adults who received a single intramuscular injection of 0.5 ml of polyvalent pseudomonas vaccine (PPV), within hours of burn injury. The response in three of these patients is compared with the response in three matched patients who did not receive the vaccine. This single dose regimen of PPV did not appear to stimulate the early production of IgG1 or IgG2 and if subclass deficiency contributes to the risk of sepsis or toxin-mediated disease, as previous workers have established (Schur et al., 1970; Oxelius et al., 1981), then there is no apparent benefit in active immunization to reduce the risk in the early postburn period.
Frame
J D
JD
North East Thames Regional Burns and Plastic Surgery Unit, St Andrew's Hospital, Billericay, Essex, UK.
Everitt
A S
AS
D000328:Adult; D000368:Aged; D001428:Bacterial Vaccines / Q000276:immunology*; D002056:Burns / Q000276:immunology* / Q000628:therapy; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000145:classification / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D011549:Pseudomonas / Q000276:immunology*; D054406:Pseudomonas Vaccines; D017778:Vaccines, Combined
D001428:Bacterial Vaccines; D007074:Immunoglobulin G; D054406:Pseudomonas Vaccines; D017778:Vaccines, Combined; C039987:polyvalent pseudomonas vaccine